KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Other Accumulated Expenses: 2009-2024

Historic Other Accumulated Expenses for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $4.3 million.

  • Dynavax Technologies' Other Accumulated Expenses rose 50.94% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 50.94%. This contributed to the annual value of $4.3 million for FY2024, which is 4.65% down from last year.
  • Dynavax Technologies' Other Accumulated Expenses amounted to $4.3 million in FY2024, which was down 4.65% from $4.5 million recorded in FY2023.
  • Over the past 5 years, Dynavax Technologies' Other Accumulated Expenses peaked at $4.8 million during FY2022, and registered a low of $3.2 million during FY2020.
  • Moreover, its 3-year median value for Other Accumulated Expenses was $4.5 million (2023), whereas its average is $4.5 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first tumbled by 67.49% in 2020, then surged by 44.38% in 2021.
  • Dynavax Technologies' Other Accumulated Expenses (Yearly) stood at $3.2 million in 2020, then surged by 44.38% to $4.7 million in 2021, then climbed by 1.86% to $4.8 million in 2022, then decreased by 5.34% to $4.5 million in 2023, then fell by 4.65% to $4.3 million in 2024.